Aarti Drugs is trading -3.19% lower at Rs 475.35 as compared to its last closing price. Aarti Drugs has been trading in the price range of 492.95 & 468.15. Aarti Drugs has given 6.62% in this year & 7.15% in the last 5 days. Aarti Drugs has TTM P/E ratio 18.50 as compared to the sector P/E of 23.19.There are 1 analysts who have initiated coverage on Aarti Drugs. There are - analysts who have given it a strong buy rating & - analysts have given it a buy rating. - analysts have given the stock a sell rating.The company posted a net profit of 62.85 Crores in its last quarter.Listed peers of Aarti Drugs include Suven Life Sciences (1.29%), Sequent Scientific (0.82%), Aarti Drugs (-3.19%).The Mutual Fund holding in Aarti Drugs was at 8.75% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Aarti Drugs was at 2.25% in 31 Mar 2025. The FII holding has decreased from the last quarter.
Updated on Jul 08, 2025, 12:03 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Suven Life Sciences | Bullish | 270.90 | 1.29 | 5,907.62 | - | 49.16 | - | - |
Sequent Scientific | Neutral | 185.00 | 0.82 | 4,626.95 | 187.66 | 6.6 | - | 42.61 |
Aarti Drugs | Bullish | 475.35 | -3.19 | 4,336.74 | 26.37 | 3.23 | 0.21 | 20.87 |
Hikal | Bearish | 344.45 | 0.80 | 4,252.63 | 85.33 | 3.39 | 0.35 | 29.28 |
Rpg Life Sciences | Bullish | 2,567.00 | -3.19 | 4,242.46 | 35.28 | 7.8 | 0.80 | - |
Meeting Date | Purpose |
---|---|
2025-05-06 | Audited Results |
2025-01-29 | Quarterly Results & Interim Dividend |
2024-10-24 | Quarterly Results |
2024-08-26 | Buy Back of Shares |
2024-07-26 | Quarterly Results |
Aarti Drugs is trading at 475.35 as on Tue Jul 08 2025 09:59:35. This is -3.19% lower as compared to its previous closing price of 491.00.
The market capitalization of Aarti Drugs is 4336.74 Cr as on Tue Jul 08 2025 09:59:35.
The 52 wk high for Aarti Drugs is 634.90 whereas the 52 wk low is 312.50
Aarti Drugs can be analyzed on the following key metrics -
Aarti Drugs reported a net profit of 168.16 Cr in 2025.
The Mutual Fund Shareholding was 8.75% at the end of 31 Mar 2025.